This study is in progress, not accepting new patients
Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)
a study on X-linked Retinoschisis
X-linked Retinoschisis XLRS maculoschisis retinal degeneration RS1 adeno-associated virus gene therapy AAV Retinoschisis rAAV2tYF-CB-hRS1
Lead Scientist at UCSF
- Anthony Moore
Professor, Ophthalmology. Authored (or co-authored) 308 research publications.